A Method for Constructing a New Extensible Nomenclature for Clinical Coding Practices in Sub-Saharan Africa
Sven Van Laere1, Marc Nyssen1, Frank Verbeke1
1Department of Public Health (GEWE), Research Group of Biostatistics and Medical Informatics (BISI), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium.
Studies in Health Technology and Informatics
|January 4, 2018
Summary
This study introduces a new clinical coding nomenclature for sub-Saharan Africa, simplifying data use for billing and clinical impact. The developed system enhances data utility for national registries and hospitals.
Area of Science:
- Health Informatics
- Medical Coding Systems
- Public Health Data Management
Background:
- Clinical coding is crucial for healthcare data in sub-Saharan Africa, supporting billing, epidemiology, and resource allocation.
- Current coding systems are often limited to billing and perceived as complex for daily clinical use.
- There's a growing recognition of the need for effective clinical data coding across health insurances, governments, and hospitals in the region.
Purpose of the Study:
- To develop a novel clinical nomenclature for sub-Saharan Africa that balances clinical impact with practical usability.
- To adapt existing coding systems by identifying a minimal, relevant subset for the region.
- To ensure the nomenclature's completeness and applicability for national health registries.
Main Methods:
- Constructing a new nomenclature by selecting a minimal subset from existing coding systems relevant to sub-Saharan Africa.
- Incorporating an extension character to manage codes applicable across multiple national registries.
- Evaluating the nomenclature's completeness against national registry requirements.
Main Results:
- A new, simplified clinical nomenclature tailored for sub-Saharan Africa has been developed.
- The nomenclature is designed for practical daily use, addressing complexity concerns.
- An extension character facilitates multi-registry data management, benefiting hospitals.
Conclusions:
- The proposed nomenclature offers a practical solution for enhancing clinical data utility in sub-Saharan Africa.
- This approach supports both billing and clinical decision-making, improving health information systems.
- The system is adaptable and beneficial for hospitals and national health data management.
Related Concept Videos
Ionic Compounds: Formulas and Nomenclature
88.2K
An element composed of atoms that readily lose electrons (a metal) can react with an element composed of atoms that readily gain electrons (a nonmetal) to produce ions through complete electron transfer. The compound formed by this transfer is stabilized by the electrostatic attractions (ionic bonds) between the oppositely charged ions.
88.2K
Molecular Compounds: Formulas and Nomenclature
56.3K
Molecular compounds or covalent compounds result when atoms share electrons to form covalent bonds. Since there is no electron transfer, molecular compounds do not contain ions; instead, they consist of discrete, neutral molecules.
56.3K
Coordination Compounds and Nomenclature
27.0K
In most main group element compounds, the valence electrons of the isolated atoms combine to form chemical bonds that satisfy the octet rule. For instance, the four valence electrons of carbon overlap with electrons from four hydrogen atoms to form CH4. The one valence electron leaves sodium and adds to the seven valence electrons of chlorine to form the ionic formula unit NaCl (Figure 1a). Transition metals do not normally bond in this fashion. They primarily form coordinate covalent bonds, a...
27.0K
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs
3.7K
3.7K
Drug Nomenclature
3.4K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.4K


